Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and apoptosis pathways
Aliskiren (ALS) is well known for its antihypertensive properties. However, the potential underlying the molecular mechanism and the anti-hypertrophic effect of ALS have not yet been fully elucidated. The aim of the present study was to investigate the role of ALS in mammalian target of rapamycin (m...
Main Authors: | Zhengbo Zhao, Han Liu, Dongmei Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2020-01-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020000200602&tlng=en |
Similar Items
-
Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway
by: Jinjing Yang, et al.
Published: (2018-09-01) -
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01) -
Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
by: Belinda Seto
Published: (2012-12-01) -
Advanced Research of mTOR and Lung Carcinoid Tumors
by: Zixuan ZHANG, et al.
Published: (2013-01-01) -
Aliskiren Improves Ischemia- and Oxygen Glucose Deprivation-Induced Cardiac Injury through Activation of Autophagy and AMP-Activated Protein Kinase
by: Ming-Hsien Chiang, et al.
Published: (2017-11-01)